Cyclophosphamide independently enhances daratumumab-mediated killing of MM cells by altering the tumor microenvironment to market macrophage recruitment, polarization to a pro-inflammatory phenotype, and directing ADCP. Springer Character continues to be neutral with regard to jurisdictional promises in revealed maps and institutional affiliations. The most loading dose and day-to-day... https://dennisa075tyd0.glifeblog.com/profile